6月12日，佐力药业获中邮证券买入评级，近一个月佐力药业获得1份研报关注。
研报预计公司2024-2026年收入分别为25.03/30.69/37.25亿元，归母净利润分别为5.30/6.91/8.86亿元。研报认为，乌灵胶囊在集采下迎来加速增长的发展机会，基于其明确的作用机理，并拥有医保甲类+基药身份，使其在城市和县级公立医院端市占率呈现持续提升趋势。此外，公司的二线品种，如灵泽片和灵莲花胶囊，也在贡献增量，未来有望保持快速的增长。
风险提示：集采下放量速度不及预期；精细化管理不及预期。
English
Back
- Markets
- Features
- News
- Community
- Learn
- Help Center
- About
- Offers & Rewards
- Welcome RewardsOpen an account and get up to HKD2000!
- Enjoy limited-time 5%+5% returns on Cash PlusInvest any amount and enjoy a 5% average return on Cash Plus + 5% welcome reward
- Join Futubull Membership ProgramUnlock 11 Premier Benefits
- Referral PromotionBring a friend and collect up to HK$600 in rewards
- Learn PremiumAnalyst 1V1 online teaching
- Stock TransferSwitch to Futu and get up to HK$7,000 in rewards
- English
- 繁體中文
- 简体中文
- Dark
- Light
- Headlines
- 佐力药业获中邮证券买入评级，乌灵胶囊受益集采量增明显
佐力药业获中邮证券买入评级，乌灵胶囊受益集采量增明显
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Hot News
Updated
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.